Shephard MD - ACELYRIN, INC Senior Development
| SLRN Stock | USD 4.55 0.02 0.44% |
Executive
Shephard MD is Senior Development of ACELYRIN, INC Common
| Address | 4149 Liberty Canyon Road, Agoura Hills, CA, United States, 91301 |
| Phone | 805-730-0360 |
| Web | https://www.acelyrin.com |
ACELYRIN, INC Management Efficiency
The company has return on total asset (ROA) of (0.3289) % which means that it has lost $0.3289 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4195) %, meaning that it created substantial loss on money invested by shareholders. ACELYRIN, INC's management efficiency ratios could be used to measure how well ACELYRIN, INC manages its routine affairs as well as how well it operates its assets and liabilities. As of the 29th of November 2024, Return On Tangible Assets is likely to drop to -0.54. In addition to that, Return On Capital Employed is likely to drop to -0.67. At this time, ACELYRIN, INC's Other Assets are very stable compared to the past year. As of the 29th of November 2024, Other Current Assets is likely to grow to about 11.1 M, while Total Assets are likely to drop about 431.9 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Jonathon Wright | Hurco Companies | 40 | |
| Roni Giladi | Sapiens International | 53 | |
| Hagit Ashkenazi | Sapiens International | N/A | |
| Chinmai Sharma | Sabre Corpo | N/A | |
| Shawn Williams | Sabre Corpo | 51 | |
| Garry Wiseman | Sabre Corpo | 47 | |
| Raj Ghuman | Sapiens International | N/A | |
| Osnat SegevHarel | Sapiens International | 62 | |
| Kevin Shannon | Inflection Point Acquisition | N/A | |
| Peter Ondishin | Inflection Point Acquisition | 37 | |
| Roshan Mendis | Sabre Corpo | 51 | |
| Jami Kindle | Sabre Corpo | 58 | |
| Kevin Crissey | Sabre Corpo | N/A | |
| Jessica Matthias | Sabre Corpo | N/A | |
| Tess Longfield | Sabre Corpo | N/A | |
| Samual Machado | Sabre Corpo | N/A | |
| Peter Johansson | CECO Environmental Corp | 60 | |
| Rochelle Boas | Sabre Corpo | N/A | |
| Asaf Amiel | Sapiens International | N/A | |
| Ann Bruder | Sabre Corpo | 60 | |
| Yaffa CohenIfrah | Sapiens International | N/A | |
Management Performance
| Return On Equity | -0.42 | ||||
| Return On Asset | -0.33 |
ACELYRIN, INC Common Leadership Team
Elected by the shareholders, the ACELYRIN, INC's board of directors comprises two types of representatives: ACELYRIN, INC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ACELYRIN,. The board's role is to monitor ACELYRIN, INC's management team and ensure that shareholders' interests are well served. ACELYRIN, INC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ACELYRIN, INC's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Patricia Turney, Chief Officer | ||
| Kenneth Lock, Chief Officer | ||
| Mina JD, CEO Director | ||
| Gilbert JD, Principal Officer | ||
| Shephard MD, Senior Development | ||
| Kelly Chow, Chief Officer | ||
| Ron Oyston, Chief Officer | ||
| Sanam JD, Chief People | ||
| Tyler Marciniak, Head Communications | ||
| Melanie BSN, Chief Officer | ||
| Suzy CPA, Senior Accounting | ||
| Mina Kim, Chief Officer | ||
| Amar JD, Chief Officer | ||
| ShaoLee MD, CEO CoFounder | ||
| MSc MD, Chief Officer |
ACELYRIN, Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ACELYRIN, INC a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.42 | ||||
| Return On Asset | -0.33 | ||||
| Current Valuation | (97.33 M) | ||||
| Shares Outstanding | 100.33 M | ||||
| Shares Owned By Insiders | 8.00 % | ||||
| Shares Owned By Institutions | 99.48 % | ||||
| Number Of Shares Shorted | 5.73 M | ||||
| Price To Book | 0.87 X | ||||
| EBITDA | (381.53 M) | ||||
| Net Income | (381.64 M) |
Pair Trading with ACELYRIN, INC
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ACELYRIN, INC position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ACELYRIN, INC will appreciate offsetting losses from the drop in the long position's value.Moving together with ACELYRIN, Stock
Moving against ACELYRIN, Stock
| 0.6 | ELAN | Elanco Animal Health Potential Growth | PairCorr |
| 0.35 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.32 | HLN | Haleon plc | PairCorr |
The ability to find closely correlated positions to ACELYRIN, INC could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ACELYRIN, INC when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ACELYRIN, INC - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ACELYRIN, INC Common to buy it.
The correlation of ACELYRIN, INC is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ACELYRIN, INC moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ACELYRIN, INC Common moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ACELYRIN, INC can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios, which includes a position in ACELYRIN, INC Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ACELYRIN, INC. If investors know ACELYRIN, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ACELYRIN, INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.46) | Return On Assets (0.33) | Return On Equity (0.42) |
The market value of ACELYRIN, INC Common is measured differently than its book value, which is the value of ACELYRIN, that is recorded on the company's balance sheet. Investors also form their own opinion of ACELYRIN, INC's value that differs from its market value or its book value, called intrinsic value, which is ACELYRIN, INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ACELYRIN, INC's market value can be influenced by many factors that don't directly affect ACELYRIN, INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ACELYRIN, INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if ACELYRIN, INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ACELYRIN, INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.